Grund Nicholas sold AKBA
February 2, 2026 · Form 4 insider transaction
Grund Nicholas sold 31,244 shares of Akebia Therapeutics, Inc. at $1.39 per share, a transaction worth $43.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
31,244
Price
$1.39
Total value
$43.4K
InsiderGrund Nicholas
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 2, 2026
Filing dateFebruary 4, 2026
Shares owned after561,750
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2025.; This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025.